Ka-ching

A huge database study reports receipt of a prescription for one of the newly-developed direct antiviral agents for chronic hepatitis C (you know, those drugs worth their weight in diamonds such as Sovaldi) is moving the needle on the incidence of hepatocellular carcinoma in addition to significantly diminishing other liver-related morbidities and overall mortality.